Back
2seventy bio Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
38
TSVT
2seventy bio
Last Price:
4.87
Seasonality Move:
-24.58%
Buy
60
BMY
Bristol-Myers Squibb
Last Price:
49.28
Seasonality Move:
4.13%
Sell
38
2seventy bio (TSVT)
is a Sell
Is 2seventy bio a Buy, Sell or Hold?
- The current 2seventy bio [TSVT] share price is $4.72. The Score for TSVT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- TSVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $49.74. The Score for BMY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TSVT Stock Price Chart
What is 2seventy bio's stock price today?
-
The 2seventy bio share price today is $4.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TSVT is experiencing slight selling pressure.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $49.74
The current trend is moderately bullish and BMY is experiencing slight buying pressure.
TSVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 55.1 | Buy |
| Chaikin Money Flow: | -88813 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.45 - 4.77) | Buy |
| Bollinger Bands (100): | (4.06 - 4.74) | Buy |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 57.34 | Buy |
| Chaikin Money Flow: | 2524777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.33 - 49.77) | Buy |
| Bollinger Bands (100): | (41.36 - 48.14) | Buy |
TSVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.63 | Buy |
| 20-day SMA: | 4.61 | Buy |
| 50-day SMA: | 4.53 | Buy |
| 200-day SMA: | 4.44 | Buy |
| 8-day EMA: | 4.67 | Buy |
| 20-day EMA: | 4.6 | Buy |
| 50-day EMA: | 4.52 | Buy |
| 200-day EMA: | 4.84 | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.12 | Buy |
| 20-day SMA: | 49.06 | Buy |
| 50-day SMA: | 47.16 | Buy |
| 200-day SMA: | 47.73 | Buy |
| 8-day EMA: | 49.35 | Buy |
| 20-day EMA: | 48.97 | Buy |
| 50-day EMA: | 47.54 | Buy |
| 200-day EMA: | 48.79 | Buy |
2seventy bio Earnings Growth & TSVT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.29 per share, and a decrease next year of $0.29 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.24 per share, a decrease this year of $6.64 per share, and an increase next year of $6.24 per share.
2seventy bio Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||